Compare MPV & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MPV | SWKH |
|---|---|---|
| Founded | 1988 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Diversified Financial Services |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.1M | 205.9M |
| IPO Year | N/A | 1999 |
| Metric | MPV | SWKH |
|---|---|---|
| Price | $19.12 | $17.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 25.2K | 8.5K |
| Earning Date | 01-01-0001 | 03-18-2026 |
| Dividend Yield | ★ 8.71% | N/A |
| EPS Growth | N/A | ★ 120.89 |
| EPS | 1.71 | ★ 1.85 |
| Revenue | N/A | ★ $40,149,000.00 |
| Revenue This Year | N/A | $52.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $9.35 | $9.36 |
| Revenue Growth | N/A | ★ 62.38 |
| 52 Week Low | $11.18 | $13.17 |
| 52 Week High | $16.42 | $20.49 |
| Indicator | MPV | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 54.07 | 52.90 |
| Support Level | $19.02 | $17.22 |
| Resistance Level | $19.60 | $17.41 |
| Average True Range (ATR) | 0.47 | 0.19 |
| MACD | 0.13 | -0.02 |
| Stochastic Oscillator | 62.15 | 56.60 |
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.